271 related articles for article (PubMed ID: 35112923)
1. Classic Thrombophilias and Thrombotic Risk Among Middle-Aged and Older Adults: A Population-Based Cohort Study.
Manderstedt E; Lind-Halldén C; Halldén C; Elf J; Svensson PJ; Dahlbäck B; Engström G; Melander O; Baras A; Lotta LA; Zöller B;
J Am Heart Assoc; 2022 Feb; 11(4):e023018. PubMed ID: 35112923
[TBL] [Abstract][Full Text] [Related]
2. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.
van Vlijmen EF; Wiewel-Verschueren S; Monster TB; Meijer K
J Thromb Haemost; 2016 Jul; 14(7):1393-403. PubMed ID: 27121914
[TBL] [Abstract][Full Text] [Related]
3.
Gemmati D; Longo G; Franchini E; Araujo Silva J; Gallo I; Lunghi B; Moratelli S; Maestri I; Serino ML; Tisato V
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34207366
[TBL] [Abstract][Full Text] [Related]
4. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
5. Thrombomodulin (THBD) gene variants and thrombotic risk in a population-based cohort study.
Manderstedt E; Halldén C; Lind-Halldén C; Elf J; Svensson PJ; Engström G; Melander O; Baras A; Lotta LA; Zöller B;
J Thromb Haemost; 2022 Apr; 20(4):929-935. PubMed ID: 34970867
[TBL] [Abstract][Full Text] [Related]
6. Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.
Moussaoui S; Saussoy P; Ambroise J; Defour JP; Zouitene R; Sifi K; Abadi N
Clin Appl Thromb Hemost; 2017 Mar; 23(2):105-115. PubMed ID: 26304686
[TBL] [Abstract][Full Text] [Related]
7. Next-Generation Sequencing of 17 Genes Associated with Venous Thromboembolism Reveals a Deficit of Non-Synonymous Variants in Procoagulant Genes.
Manderstedt E; Lind-Halldén C; Svensson P; Zöller B; Halldén C
Thromb Haemost; 2019 Sep; 119(9):1441-1450. PubMed ID: 31352677
[TBL] [Abstract][Full Text] [Related]
8. The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism.
Caiano L; Kovacs MJ; Lazo-Langner A; Anderson DR; Kahn SR; Shah V; Kaatz S; Zide RS; Schulman S; Chagnon I; Mallick R; Rodger MA; Wells PS
J Thromb Haemost; 2023 Mar; 21(3):553-558. PubMed ID: 36710196
[TBL] [Abstract][Full Text] [Related]
9. Classic thrombophilic gene variants.
Mannucci PM; Franchini M
Thromb Haemost; 2015 Nov; 114(5):885-9. PubMed ID: 26018405
[TBL] [Abstract][Full Text] [Related]
10. Multilocus genetic risk scores for venous thromboembolism risk assessment.
Soria JM; Morange PE; Vila J; Souto JC; Moyano M; Trégouët DA; Mateo J; Saut N; Salas E; Elosua R
J Am Heart Assoc; 2014 Oct; 3(5):e001060. PubMed ID: 25341889
[TBL] [Abstract][Full Text] [Related]
11. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
Méan M; Limacher A; Stalder O; Angelillo-Scherrer A; Alberio L; Fontana P; Beer HJ; Rodondi N; Lämmle B; Aujesky D
Am J Med; 2017 Oct; 130(10):1220.e17-1220.e22. PubMed ID: 28606797
[TBL] [Abstract][Full Text] [Related]
12. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M;
Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523
[TBL] [Abstract][Full Text] [Related]
13. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism in neonates and children.
Kenet G; Nowak-Göttl U
Best Pract Res Clin Haematol; 2012 Sep; 25(3):333-44. PubMed ID: 22959549
[TBL] [Abstract][Full Text] [Related]
15. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
[TBL] [Abstract][Full Text] [Related]
16. The genetics of venous thromboembolism: a systematic review of thrombophilia families.
Zhang Y; Zhang Z; Shu S; Niu W; Xie W; Wan J; Zhai Z; Wang C
J Thromb Thrombolysis; 2021 Feb; 51(2):359-369. PubMed ID: 32623564
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic Risk Determined by Protein C Receptor (PROCR) Variants among Middle-Aged and Older Adults: A Population-Based Cohort Study.
Manderstedt E; Halldén C; Lind-Halldén C; Elf J; Svensson PJ; Engström G; Melander O; Baras A; Lotta LA; Zöller B;
Thromb Haemost; 2022 Aug; 122(8):1326-1332. PubMed ID: 35021256
[TBL] [Abstract][Full Text] [Related]
18. Thrombophilia and risk of VTE recurrence according to the age at the time of first VTE manifestation.
Weingarz L; Schindewolf M; Schwonberg J; Hecking C; Wolf Z; Erbe M; Lindhoff-Last E; Linnemann B
Vasa; 2015 Jul; 44(4):313-23. PubMed ID: 26314364
[TBL] [Abstract][Full Text] [Related]
19. Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes.
Segers O; Simioni P; Tormene D; Castoldi E
Thromb Haemost; 2014 Mar; 111(3):438-46. PubMed ID: 24226152
[TBL] [Abstract][Full Text] [Related]
20. Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients.
Wahba MA; Ismail MA; Saad AA; Habashy DM; Hafeez ZM; Boshnak NH
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):309-15. PubMed ID: 25565385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
